¼¼°èÀÇ ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½ÃÀå
Microneedle Patches
»óǰÄÚµå : 1793037
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 290 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License)
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)


Çѱ۸ñÂ÷

¼¼°èÀÇ ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½ÃÀåÀº 2030³â±îÁö 12¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 8¾ï 8,240¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 12¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ °íü ¸¶ÀÌÅ©·Î´ÏµéÀº CAGR 7.2%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 4¾ï 8,810¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß°ø ¸¶ÀÌÅ©·Î´Ïµé ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 4,040¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¾î Áß±¹Àº CAGR 8.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÈ´Ù

¹Ì±¹ÀÇ ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½ÃÀåÀº 2024³â¿¡ 2¾ï 4,040¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â°£ CAGR 8.9%·Î 2030³â±îÁö 2¾ï 4,760¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.5%¿Í 5.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.5%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡°¡ ¾à¹° Àü´Þ ¹× ÇǺΠ°ü¸® ±â¼úÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â ÇǺθ¦ ÅëÇØ Ȱ¼º È­ÇÕ¹°À» Åõ¿©ÇÏ´Â Àúħ½ÀÀû, ¹«ÅëÁõ, È¿À²ÀûÀÎ ¹æ¹ýÀ» Á¦°øÇÔÀ¸·Î½á ¾à¹° Àü´Þ ¹× ÇǺΠ°ü¸®ÀÇ »óȲÀ» ºü¸£°Ô º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ ÆÐÄ¡´Â ÇǺΠ¿ÜÃþ¿¡ ÃʼÒÇü ä³ÎÀ» Çü¼ºÇÏ´Â ¹Ì¼¼ÇÑ ¹Ù´Ã ¹è¿­·Î ±¸¼ºµÇ¾î ÀÖ¾î ¾à¹°, ¹é½Å, È­Àåǰ ¼ººÐÀ» ÁøÇÇ¿¡ Á÷Á¢, Á¦¾îµÈ ÇüÅ·ΠÀü´ÞÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ÇÇÇÏ ÁÖ»ç ¹Ù´Ã°ú ´Þ¸® ¸¶ÀÌÅ©·Î´ÏµéÀº ÅëÁõÀ» °ÅÀÇ ´À³¢Áö ¾Êµµ·Ï ¼³°èµÇ¾î ¾î¸°ÀÌ, ³ëÀÎ, ÁÖ»ç¹Ù´Ã °øÆ÷ÁõÀÌ ÀÖ´Â »ç¶÷µé¿¡°Ô ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù. ÆÐÄ¡´Â »ýüÀûÇÕ¼º °íºÐÀÚ, ½Ç¸®ÄÜ, ±Ý¼ÓÀ¸·Î ¸¸µé ¼ö ÀÖÀ¸¸ç, Ä¡·á ¸ñÀû¿¡ µû¶ó ÇǺΠ³»¿¡¼­ ³ì°Å³ª ±×´ë·Î ³²¾ÆÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº Àν¶¸°, Ç×¾ÏÁ¦, È£¸£¸ó, ¹é½Å µîÀÇ Àü´Þ°ú ³ëÈ­¹æÁö Ä¡·á, ¿©µå¸§ °ü¸® µî È­Àåǰ¿¡ Àû¿ëµÉ ¼ö ÀÖ´Â °¡´É¼ºÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ½ºÅ²Äɾ¼­´Â ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡¸¦ ÅëÇØ È÷¾Ë·ç·Ð»ê, ÆéŸÀ̵å, ºñŸ¹ÎÀÇ Ä§Åõ¸¦ ÃËÁøÇÏ¿© ÇǺÎÅæ, ÇǺΰá, º¸½ÀÀÌ ´«¿¡ ¶ç°Ô °³¼±µË´Ï´Ù. ¶ÇÇÑ, ÀÌ ÆÐÄ¡´Â ÀÚ°¡ Åõ¿©°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ ÀçÅà ġ·á¿¡ ÀÌ»óÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î ÀÓ»ó ¹æ¹®ÀÇ Çʿ伺À» ÁÙÀ̰í Ä¡·á ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ º¸´Ù Á¢±ÙÇϱ⠽±°í, °³ÀÎÈ­µÇ°í, »ç¿ëÀÚ Ä£È­ÀûÀÎ Ä¡·á ¿É¼ÇÀ» Ãß±¸Çϰí ÀÖ´Â °¡¿îµ¥, ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â Á¦¾à °úÇаú ¼ÒºñÀÚ À£ºùÀ» ¿¬°áÇÏ´Â ´ÙÀç´Ù´ÉÇÑ Ç÷§ÆûÀ» Á¦°øÇÕ´Ï´Ù. ÄÄÆÑÆ®ÇÑ µðÀÚÀΰú ±ä º¸°ü ±â°£À¸·Î ³ÃÀå ½Ã¼³À̳ª ¼÷·ÃµÈ Á÷¿øÀÌ ¾ø´Â ¿Üµý Áö¿ªÀ̳ª ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­µµ »ç¿ëÇϱ⿡ ÀûÇÕÇÕ´Ï´Ù. ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â ¼ÒÀç¿Í Á¦Á¶ °øÁ¤ÀÇ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀ» ÅëÇØ ÀÇ·á¿ë ¹× È­Àåǰ¿ë Á¦Ç°ÀÇ ÁÖ·Â Á¦Ç°ÀÌ µÉ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¹«Åë, Æí¸®ÇÑ ¹è¼Û ¹æ½Ä¿¡ ´ëÇÑ ¿ä±¸°¡ ½ÃÀå º¸±ÞÀ» ÃËÁøÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¹«ÅëÀÇ Æí¸®ÇÑ ¾à¹° Àü´Þ ¹× ½ºÅ²Äɾî Àü´Þ ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¹× È­Àåǰ ºÐ¾ß¿¡¼­ ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ÀÇ Ã¤ÅÃÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ¿Í È¯ÀÚµéÀº ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϰí, »ç¿ëÀÌ °£ÆíÇϸç, ÀÏ»ó»ýȰ¿¡ ÁöÀåÀ» ÁÖÁö ¾Ê´Â Ä¡·á¸¦ ¿øÇϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ÁÖ»ç Ä¡·á´Â ºÒ¾È°¨, ÅëÁõ, °¨¿°, Ÿ¹Ú»ó µîÀÇ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ¾î ó¹æµÈ ¿ä¹ýÀ» ÁöŰ´Â °ÍÀ» ÁÖÀúÇÏ´Â »ç¶÷µéµµ ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â ÀÌ·¯ÇÑ ¿ì·Á¸¦ ºÒ½Ä½Ãų ¼ö ÀÖµµ·Ï ÅëÁõÀÌ °ÅÀÇ ¾ø°í, Àü¹®Àû ÈÆ·Ã ¾øÀ̵µ ½Ã¼úÀÌ °¡´ÉÇϸç, ÇÕº´Áõ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ´ç´¢, È£¸£¸ó º¸Ãæ, ÆíµÎÅë µî Á¤±âÀûÀÎ Åõ¾àÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯÀڵ鿡°Ô´Â ±× Æí¸®ÇÔÀÌ ¸Å¿ì ¸Å·ÂÀûÀÔ´Ï´Ù. È­Àåǰ ºÐ¾ß¿¡¼­µµ ¼ÒºñÀÚµéÀº °ªºñ½Î°í ½Ã°£ÀÌ ¸¹ÀÌ ¼Ò¿äµÇ´Â º´¿ø Ä¡·á ¾øÀ̵µ Àü¹®°¡ ¼öÁØÀÇ °á°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â ºñħ½ÀÀû ´ë¾È¿¡ ¸Å·ÂÀ» ´À³¢°í ÀÖ½À´Ï´Ù. Äڷγª19 ÆÒµ¥¹Í ±â°£ µ¿¾È °¡Á¤¿ë ¹Ì¿ë ¹× °Ç°­ ±â±âÀÇ ºÎ»óÀº ÀÌ·¯ÇÑ º¯È­¸¦ ´õ¿í ÁõÆø½ÃÄÑ ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡¿Í °°Àº °í¼º´É ¼¿ÇÁ ÄÉ¾î µµ±¸¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ Áö¼ÓÀûÀÎ °ü½ÉÀ» ºÒ·¯ÀÏÀ¸Ä×½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¶óÀÌÇÁ½ºÅ¸ÀÏÀÌ ¸ð¹ÙÀÏÈ­µÇ°í °Ç°­ ÁöÇ⼺ÀÌ ³ô¾ÆÁü¿¡ µû¶ó ´«¿¡ ¶çÁö ¾Ê°í À̵¿ Áß¿¡µµ »ç¿ëÇÒ ¼ö ÀÖ´Â Á¦Ç°ÀÌ Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Ã°£ Á¦¾î ¹æÃâ ¹× Ç¥Àû Àü´ÞÀ» À§ÇØ ÆÐÄ¡¸¦ ¼³°èÇÏ´Â ´É·ÂÀº ¾àµ¿ÇÐÀ» °³¼±Çϰí Àü½Å ºÎÀÛ¿ëÀ» ÁÙÀÓÀ¸·Î½á ÀÓ»óÀû À¯¿ë¼ºÀ» ³ôÀÔ´Ï´Ù. Á¦Á¶¾÷üÀÇ °æ¿ì, ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ÀÇ È®À强°ú Æ÷ÀåÀÇ ¿ëÀ̼ºÀº ¹°·ù ¹× À¯Åë Ãø¸é¿¡¼­ ÀÌÁ¡ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â ÀÌ·¯ÇÑ »ç¿ëÀÚ °æÇè¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ°í ÀÖ°í, ¼ºÀû È¿´ÉÀÌ ÀÔÁõµÈ ¸¸Å­ Â÷¼¼´ë ÇコÄÉ¾î ¹× ½ºÅ²ÄÉ¾î ¼Ö·ç¼ÇÀ¸·Î ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½Ã½ºÅÛÀÇ ´É·ÂÀ» ¾î¶»°Ô È®ÀåÇϰí Àִ°¡?

±â¼ú Çõ½ÅÀº ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½Ã½ºÅÛÀÇ ´É·ÂÀ» ºü¸£°Ô È®ÀåÇÏ¿© ´õ ³ÐÀº Àû¿ë ¹üÀ§, Çâ»óµÈ È¿°ú ¹× »ç¿ëÀÚ Á¤ÀÇ °¡´É¼ºÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ·¹ÀÌÀú Ä¿ÆÃ, ¸®¼Ò±×·¡ÇÇ, 3D ÇÁ¸°ÆÃ µî ¹Ì¼¼ °¡°ø ±â¼úÀÇ ¹ß´Þ·Î ¹Ù´ÃÀÇ ¸ð¾ç, Å©±â, ¹Ðµµ¸¦ Á¤È®ÇÏ°Ô Á¦¾îÇÒ ¼ö ÀÖ°Ô µÇ¾úÀ¸¸ç, ÀÌ´Â ÇǺο¡ ¹°ÁúÀÌ Àü´ÞµÇ´Â ¹æ½Ä¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ¸¶ÀÌÅ©·Î´Ïµé ¾î·¹À̸¦ ƯÁ¤ Ä¡·á ¿ä°Ç¿¡ ¸Â°Ô Á¶Á¤ÇÒ ¼ö ÀÖ°Ô µÇ¾î ´Ù¾çÇÑ »ç¿ëÀÚ ÇÁ·ÎÆÄÀÏ¿¡ °ÉÃÄ ÀϰüµÈ ¼º´ÉÀ» º¸ÀåÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. »õ·Î¿î »ýºÐÇØ¼º ¹× ¿ëÇØ¼º Æú¸®¸Ó´Â »õ·Î¿î »ýºÐÇØ¼º ¹× ¿ëÇØ¼º Æú¸®¸Ó¸¦ ÅëÇØ ÆÐÄ¡ Á¦°ÅÀÇ Çʿ伺À» ¾ø¾Ö°í Æó±â¹°À» ÁÙÀÌ´Â ¿ÏÀü Èí¼ö¼º ¸¶ÀÌÅ©·Î´Ïµé ¶ÇÇÑ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¼¾¼­¿Í ¹ÝÀÀ¼º ¹°ÁúÀ» ³»ÀåÇÑ ½º¸¶Æ® ¸¶ÀÌÅ©·Î´ÏµéÀº ¿Âµµ, pH, Æ÷µµ´ç ¼öÄ¡ µîÀÇ »ý¸®Àû ½ÅÈ£¿¡ ¹ÝÀÀÇÏ¿© ¾à¹°À» Àü´ÞÇÒ ¼ö ÀÖ°Ô µÇ¾î ½Ç½Ã°£ ÀûÀÀ Ä¡·á°¡ °¡´ÉÇØÁ³½À´Ï´Ù. À̴ ƯÈ÷ ¸¸¼ºÁúȯ °ü¸®¿¡¼­ Àû½Ã¿¡ °³º°È­µÈ Åõ¿©°¡ °á°ú¸¦ Å©°Ô °³¼±ÇÏ´Â ¸¸¼ºÁúȯ °ü¸®¿¡¼­ ƯÈ÷ À¯¸ÁÇÕ´Ï´Ù. ÆÐÄ¡ »ç¿ëÀ» ÃßÀûÇϰí, ȯÀÚÀÇ ¼øÀÀµµ¸¦ ¸ð´ÏÅ͸µÇϰí, »ç¿ëÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô Çǵå¹éÀ» Á¦°øÇϱâ À§ÇØ ¿þ¾î·¯ºí ±â±â ¹× ¸ð¹ÙÀÏ ¾Û°úÀÇ ÅëÇÕÀ» °í·ÁÇϰí ÀÖ½À´Ï´Ù. È­Àåǰ¿¡ Àû¿ëµÉ °æ¿ì, ¸¶ÀÌÅ©·Î´Ïµé ³»¿¡ ³ª³ë ij¸®¾î³ª ĸ½¶È­µÈ Ȱ¼ºÁ¦¸¦ Æ÷ÇÔ½ÃÅ´À¸·Î½á ÀϹÝÀûÀ¸·Î ºÒ¾ÈÁ¤Çϰųª Èí¼ö°¡ Àß µÇÁö ¾Ê´Â È­ÇÕ¹°À» Àü´ÞÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÆÐÄ¡´Â ´Ù¾çÇÑ ÇǺΠ±íÀÌ¿¡ ħÅõÇϵµ·Ï ¼³°èµÇ¾î °æÇÇ ¾à¹° Àü´Þ¿¡¼­ Çdz» ¹é½Å Á¢Á¾¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ¿¡ ÀûÇÕÇÕ´Ï´Ù. ¶ÇÇÑ, ±â¼úÀû °³¼±À» ÅëÇØ Á¦Á¶ ºñ¿ëÀ» Àý°¨Çϰí Á¦Á¶ È®À强À» Çâ»ó½ÃÄÑ ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡¸¦ º¸´Ù ±¤¹üÀ§ÇÑ ½ÃÀå¿¡¼­ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀ¸·Î ¸¶ÀÌÅ©·Î´ÏµéÀº Æ´»õ ±â¼ú Çõ½Å¿¡¼­ ¹Ì·¡ÀÇ Ä¡·á¿Í ¹Ì¿ë ¹ßÀüÀ» À§ÇÑ ±âÃÊ Ç÷§ÆûÀ¸·Î º¯¸ðÇϰí ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ÃÖ¼Òħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ȨÄÉ¾î ¼Ö·ç¼ÇÀ¸·ÎÀÇ Àüȯ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ÃËÁø¿äÀÎ Áß Çϳª´Â ´ç´¢º´, ½ÉÇ÷°üÁúȯ, ÀÚ°¡¸é¿ªÁúȯ°ú °°Àº ºñ°¨¿°¼º ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Àå±âÀûÀÎ º¹¾à ¼øÀÀµµ¸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù. ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â ȯÀÚ Ä£È­ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á ¼øÀÀµµ¸¦ ³ôÀ̰í, »îÀÇ ÁúÀ» Çâ»ó½Ã۸ç, ȯÀÚ Ä£È­ÀûÀÎ ´ë¾ÈÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ¿Í ÇÔ²² È­Àåǰ ¾÷°è¿¡¼­´Â ºñħ½ÀÀûÀÌ°í °úÇÐÀûÀÎ ±Ù°Å¿¡ ±â¹ÝÇÑ ½ºÅ²ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡´Â Ŭ¸° ºäƼ¿Í ȨÄÉ¾î Æ®·»µå¿¡ µû¶ó ÇÁ¸®¹Ì¾ö Á¦Ç° Ä«Å×°í¸®·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦±â°üµµ ¸¶ÀÌÅ©·Î´Ïµé ½Ã½ºÅÛÀÇ °¡´É¼ºÀ» ÀνÄÇϰí ÁöÁöÇϱ⠽ÃÀÛÇßÀ¸¸ç, ¿©·¯ ÀÓ»ó½ÃÇè°ú Á¦Ç° ½ÂÀÎÀ» ÅëÇØ ±× ¾ÈÀü¼º°ú È¿°ú¿¡ ´ëÇÑ ½Å·Ú°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Á¦Á¶ ¹× Àç·á °úÇÐÀÇ ¹ßÀüÀº Á¦Á¶ ºñ¿ëÀ» ³·Ãß°í È®À强À» ³ôÀ̰í ÀÖÀ¸¸ç, ÀÌ ±â¼úÀº ¼±Áø±¹°ú ½ÅÈï±¹ ½ÃÀå ¸ðµÎ¿¡¼­ ½ÇÇà °¡´ÉÇÑ ±â¼úÀÔ´Ï´Ù. Á¦¾àȸ»ç, È­Àåǰ ºê·£µå, ±â¼ú ±â¾÷ °£ÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀº Á¦Ç° °³¹ßÀ» °¡¼ÓÈ­Çϰí À¯Åë¸ÁÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ¿¹¹æÁ¢Á¾·üÀ» ³ôÀ̰í ÄݵåüÀÎ ¹°·ù¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß±â À§ÇÑ °øÁߺ¸°Ç ³ë·ÂÀº ƯÈ÷ ¿Üµý Áö¿ªÀ̳ª ÀÇ·á¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ¿¹¹æÁ¢Á¾À» º¸±ÞÇϱâ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡¸¦ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ ¸¶ÄÉÆÃ, ±³À° Ä·ÆäÀÎ, ÀÎÇ÷ç¾ð¼­µéÀÇ ÁöÁö¸¦ ¹ÙÅÁÀ¸·Î ÇÑ ÀÎÁöµµ Çâ»óÀº ¼ÒºñÀÚÀÇ °ü½ÉÀ» ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ¸¶ÀÌÅ©·Î´Ïµé ÆÐÄ¡ ½ÃÀåÀº Áö¼Ó °¡´ÉÇÑ ¼ºÀåÀ» À§ÇÑ À¯¸®ÇÑ È¯°æÀÌ Á¶¼ºµÇ°í ÀÖÀ¸¸ç, ÇコÄɾî Çõ½Å, ¼ÒºñÀÚ ±ÇÇÑ ºÎ¿©, ¼¼°è À£´Ï½º Æ®·»µåÀÇ ±³Â÷Á¡¿¡ ÀÌ ±â¼úÀ» ¹èÄ¡Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(°íü ¸¶ÀÌÅ©·Î´Ïµé, Áß°ø ¸¶ÀÌÅ©·Î´Ïµé, ¿ëÇØ ¸¶ÀÌÅ©·Î´Ïµé, ÄÚÆÃ ¸¶ÀÌÅ©·Î´Ïµé);ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ÃÖÁ¾»ç¿ëÀÚ, Àü¹® Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, Çмú±â°ü ÃÖÁ¾»ç¿ëÀÚ, ¿¬±¸±â°ü ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Microneedle Patches Market to Reach US$1.2 Billion by 2030

The global market for Microneedle Patches estimated at US$882.4 Million in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Solid Microneedles, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$488.1 Million by the end of the analysis period. Growth in the Hollow Microneedles segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$240.4 Million While China is Forecast to Grow at 8.9% CAGR

The Microneedle Patches market in the U.S. is estimated at US$240.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$247.6 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Microneedle Patches Market - Key Trends & Drivers Summarized

How Are Microneedle Patches Transforming Drug Delivery and Skincare Technologies?

Microneedle patches are rapidly transforming the landscape of drug delivery and skincare by offering a minimally invasive, painless, and efficient method of administering active compounds through the skin. These patches consist of arrays of microscopic needles that create tiny channels in the outer layer of the skin, allowing for the direct and controlled delivery of drugs, vaccines, or cosmetic ingredients into the dermis. Unlike traditional hypodermic needles, microneedles are designed to be virtually painless, making them especially appealing for pediatric, geriatric, and needle-phobic populations. The patches can be made from biocompatible polymers, silicon, or metals and can either dissolve in the skin or remain intact depending on the therapeutic goal. This technology has demonstrated strong potential in the delivery of insulin, cancer drugs, hormones, and vaccines, as well as in cosmetic applications like anti-aging treatments and acne management. In skincare, microneedle patches are enabling enhanced penetration of hyaluronic acid, peptides, and vitamins, offering visible improvements in skin tone, texture, and hydration. Furthermore, the ease of self-administration makes these patches an ideal solution for home-based care, reducing the need for clinical visits and improving treatment adherence. As global health systems push for more accessible, personalized, and user-friendly treatment options, microneedle patches offer a versatile platform that bridges pharmaceutical science and consumer wellness. Their compact design and long shelf-life also make them suitable for use in remote or resource-limited settings where refrigeration or trained personnel may not be available. With continued innovation in materials and manufacturing processes, microneedle patches are expected to become a mainstay in both medical and cosmetic product portfolios.

Why Is the Push for Painless, Convenient Delivery Methods Fueling Market Adoption?

The growing demand for painless and convenient drug and skincare delivery methods is significantly fueling the adoption of microneedle patches across both medical and cosmetic sectors. Consumers and patients increasingly seek treatments that minimize discomfort, are easy to use, and do not disrupt their daily routines. Traditional injection-based therapies can cause anxiety, pain, and complications such as infections or bruising, deterring some individuals from adhering to prescribed regimens. Microneedle patches eliminate these concerns by offering a virtually pain-free experience, requiring no specialized training to administer and posing minimal risk of complications. Their convenience makes them highly attractive for chronic conditions requiring regular dosing, such as diabetes, hormone replacement, or migraines. In the realm of cosmetics, consumers are gravitating toward non-invasive alternatives that deliver professional-grade results without the need for expensive or time-consuming in-office treatments. The rise of at-home beauty and wellness devices during the COVID-19 pandemic further amplified this shift, creating lasting consumer interest in high-performance, self-care tools like microneedle patches. As global lifestyles become more mobile and health-conscious, products that support discreet and on-the-go use are becoming increasingly desirable. Additionally, the ability to design patches for time-controlled release or targeted delivery enhances their clinical utility by improving pharmacokinetics and reducing systemic side effects. For manufacturers, the scalability and ease of packaging of microneedle patches provide advantages in terms of logistics and distribution. This growing emphasis on user experience, coupled with proven performance benefits, is making microneedle patches a preferred modality for next-generation healthcare and skincare solutions.

How Are Technological Advances Expanding the Capabilities of Microneedle Patch Systems?

Technological innovation is rapidly expanding the capabilities of microneedle patch systems, enabling a wider range of applications, improved efficacy, and increased customization. Developments in microfabrication techniques such as laser cutting, lithography, and 3D printing have allowed for precise control over needle geometry, size, and density, which directly influence how substances are delivered into the skin. These advances make it possible to tailor microneedle arrays to specific treatment requirements, ensuring consistent performance across diverse user profiles. Materials science is also playing a crucial role, with new biodegradable and dissolvable polymers allowing for fully absorbable microneedles that eliminate the need for patch removal and reduce waste. Smart microneedles embedded with sensors or responsive materials can now deliver drugs in response to physiological cues like temperature, pH, or glucose levels, enabling real-time adaptive therapies. This is particularly promising in managing chronic diseases, where timely and individualized dosing can significantly improve outcomes. Integration with wearable devices and mobile apps is being explored to track patch usage, monitor patient compliance, and provide feedback to both users and healthcare providers. In cosmetic applications, the inclusion of nanocarriers or encapsulated actives within microneedles is enabling the delivery of otherwise unstable or poorly absorbed compounds. Furthermore, patches are being designed to penetrate different skin depths, making them suitable for applications ranging from transdermal drug delivery to intradermal vaccinations. Technological refinement is also reducing manufacturing costs and increasing production scalability, making microneedle patches more accessible to a broader market. These technological strides are transforming microneedles from a niche innovation into a foundational platform for future therapeutic and cosmetic advancements.

What Are the Main Factors Driving Global Growth in the Microneedle Patches Market?

The growth in the microneedle patches market is driven by several key factors, including the rising prevalence of chronic diseases, the increasing demand for minimally invasive treatments, and the global shift toward home-based care solutions. One of the most important drivers is the growing burden of non-communicable diseases such as diabetes, cardiovascular conditions, and autoimmune disorders, which require long-term medication adherence. Microneedle patches offer a patient-friendly alternative that enhances compliance and improves quality of life. In parallel, the cosmetic industry is experiencing a boom in demand for non-invasive, science-driven skincare solutions, with microneedle patches emerging as a premium product category that aligns with clean beauty and at-home treatment trends. Regulatory bodies are also beginning to recognize and support the potential of microneedle systems, with several clinical trials and product approvals signaling growing confidence in their safety and efficacy. Advances in manufacturing and material science are lowering production costs and increasing scalability, making the technology viable for both developed and emerging markets. Strategic partnerships between pharmaceutical companies, cosmetic brands, and technology firms are accelerating product development and expanding distribution networks. Public health initiatives aimed at improving vaccination rates and reducing dependency on cold chain logistics are also spotlighting microneedle patches as an innovative solution for widespread immunization, particularly in remote or underserved areas. Rising awareness, supported by digital marketing, educational campaigns, and influencer endorsements, is further fueling consumer interest. Together, these factors are creating a favorable environment for sustained growth in the microneedle patches market, positioning the technology at the intersection of healthcare innovation, consumer empowerment, and global wellness trends.

SCOPE OF STUDY:

The report analyzes the Microneedle Patches market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Solid Microneedles, Hollow Microneedles, Dissolving Microneedles, Coated Microneedles); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use, Academic Institutions End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â